Genipin-crosslinked albumin nanoparticles containing neratinib and silibinin: A dual-death therapy for triple negative breast cancer
Rohan Ghadi, Pawan Kumar Pandey, Akash Gabhale, Aaradhya Wadikar, M. Dharshini, Kaushik Kuche, Tushar Date, Sanyog Jain
Topics & Concepts
SilibininProgrammed cell deathChemistryNanocarriersApoptosisReactive oxygen speciesCytotoxicityPaclitaxelPharmacologyCancer researchDrug deliveryBiochemistryMedicineIn vitroCancerInternal medicineOrganic chemistryDrug Transport and Resistance MechanismsFerroptosis and cancer prognosisCancer, Lipids, and Metabolism